Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002350
Filing Date
2008-03-07
Accepted
2008-03-07 14:58:35
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183324z10-k.htm 10-K 784412
2 EXHIBIT 10.26 a2183324zex-10_26.htm EX-10.26 96793
3 EXHIBIT 10.27 a2183324zex-10_27.htm EX-10.27 14049
4 EXHIBIT 23.1 a2183324zex-23_1.htm EX-23.1 3727
5 EXHIBIT 31.1 a2183324zex-31_1.htm EX-31.1 7073
6 EXHIBIT 31.2 a2183324zex-31_2.htm EX-31.2 7094
7 EXHIBIT 32.1 a2183324zex-32_1.htm EX-32.1 4616
8 G927717.JPG g927717.jpg GRAPHIC 20610
  Complete submission text file 0001047469-08-002350.txt   947683
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 08673920
SIC: 2834 Pharmaceutical Preparations